Why the study?
Does QiShenYiQi pill improve myocardial collagen metabolism in rats with partial abdominal aortic coarctation?
Does QiShenYiQi pill improve myocardial collagen metabolism in rats with partial abdominal aortic coarctation?
QiShenYiQi pill improves myocardial fibrosis and collagen metabolism in a rat model of partial abdominal aortic coarctation by regulating MMP-1 and TIMP-1 expression.
Answers are grounded in this paper and cite their sources.
Should not change practice; extends preclinical evidence on QSYQ for myocardial fibrosis in rats.
This study investigated the effect of QiShenYiQi pill (QSYQ) on myocardial collagen metabolism in rats with partial abdominal aortic coarctation and explored its mechanism of action. A series of assays were used to detect the effect and mechanism of QSYQ on systolic blood pressure, heart mass index, left ventricle mass index, HYP, expression of PICP, PIIINT, and CTX-I in serum, MMP-1, and TIMP-1 expression in myocardium. We observed that QSYQ can reduce the rate of myocardial collagen synthesis and increase the rate of myocardial collagen degradation. It also effectively improved the degree of myocardial fibrosis in partial abdominal aortic rats and it had a tendency to have a greater effect with longer treatment duration, which is related to the mechanism of regulation of MMP-1 and TIMP-1 expression in the myocardial rat.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: